Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.

Llach J, Ginès P, Arroyo V, Rimola A, Titó L, Badalamenti S, Jiménez W, Gaya J, Rivera F, Rodés J.

Gastroenterology. 1988 Feb;94(2):482-7.

PMID:
3335320
2.

A prognostic model for predicting survival in cirrhosis with ascites.

Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J.

J Hepatol. 2001 Jan;34(1):46-52.

PMID:
11211907
3.

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, Clària J, Rimola A, Arroyo V, et al.

Gastroenterology. 1993 Jul;105(1):229-36.

PMID:
8514039
4.

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.

Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.

Hepatology. 1998 Oct;28(4):937-43.

PMID:
9755229
5.

Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.

Saló J, Guevara M, Fernández-Esparrach G, Bataller R, Ginès A, Jimenez W, Ginès P, Rivera F, Arroyo V, Rodés J.

Hepatology. 1997 Jun;25(6):1338-42.

PMID:
9185749
6.

Effects of somatostatin on renal function in cirrhosis.

Ginès A, Salmerón JM, Ginès P, Jiménez W, Saló J, Piera C, Clària J, Rivera F, Arroyo V, Rodés J.

Gastroenterology. 1992 Dec;103(6):1868-74.

PMID:
1360435
7.

Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis.

Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, Gatta A.

J Hepatol. 1998 Jan;28(1):115-21.

PMID:
9537848
8.

Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.

Pariente EA, Bataille C, Bercoff E, Lebrec D.

Gastroenterology. 1985 May;88(5 Pt 1):1255-9.

PMID:
3884428
9.

Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis.

Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ.

J Hepatol. 1988 Jun;6(3):350-8.

PMID:
3392385
10.

Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.

Am J Gastroenterol. 1997 Mar;92(3):394-9.

PMID:
9068457
11.

Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure.

Fang JT, Tsai MH, Tian YC, Jenq CC, Lin CY, Chen YC, Lien JM, Chen PC, Yang CW.

Nephrol Dial Transplant. 2008 Jun;23(6):1961-9. doi: 10.1093/ndt/gfm914. Epub 2008 Jan 10.

PMID:
18187499
12.

Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.

Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Christos P, Paraskevi K, Konstantinos P, Katsaraki A, Tsianos EV.

Dig Dis Sci. 2005 Oct;50(10):1771-7.

PMID:
16187171
13.

Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.

Salerno F, Borroni G, Moser P, Badalamenti S, Cassarà L, Maggi A, Fusini M, Cesana B.

Am J Gastroenterol. 1993 Apr;88(4):514-9.

PMID:
8470631
14.

Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.

Merkel C, Bolognesi M, Finucci GF, Angeli P, Caregaro L, Rondana M, Gatta A.

J Hepatol. 1989 Jul;9(1):16-22.

PMID:
2768794
15.

Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation.

Magliocchetti N, Torchio P, Corrao G, Aricò S, Favilli S.

Ital J Gastroenterol Hepatol. 1997 Feb;29(1):38-46.

PMID:
9265577
16.

Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.

La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.

Am J Gastroenterol. 1997 May;92(5):852-7.

PMID:
9149200
17.
18.

Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study.

Papadakis MA, Arieff AI.

Am J Med. 1987 May;82(5):945-52.

PMID:
3578363
19.

Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding.

Patch D, Armonis A, Sabin C, Christopoulou K, Greenslade L, McCormick A, Dick R, Burroughs AK.

Gut. 1999 Feb;44(2):264-9.

20.

Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.

Kojima H, Tsujimoto T, Uemura M, Takaya A, Okamoto S, Ueda S, Nishio K, Miyamoto S, Kubo A, Minamino N, Kangawa K, Matsuo H, Fukui H.

J Hepatol. 1998 May;28(5):840-6.

PMID:
9625320

Supplemental Content

Support Center